tiprankstipranks

Julie Garlikov Insider Profile

4 Followers
Julie Garlikov, CMO at NewAge, holds 858.00 shares in NovaBay Pharma (Ticker: NBY), holds 74.63K shares in NewAge (Ticker: NBEVQ).
tipranks
Julie Garlikov

Julie Garlikov
NewAge (NBEVQ)
CMO

Not Ranked
Julie Garlikov has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$69
100.00%
A breakdown of Julie Garlikov's holdings

Insider Roles

NovaBay Pharma
(NBY)
Director
Roles that Julie Garlikov holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Julie Garlikov

Julie Garlikov's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NBEVQ
NewAge
Nov 06, 2019
Uninformative Buy
$1.49K
NovaBay Pharma
May 15, 2023
Director
Uninformative Buy
$68.64
List of latest transactions for each holding click on a transaction to see Julie Garlikov's performance on stock

Julie Garlikov insider profile FAQ

What is the percentage of profitable transactions made by Julie Garlikov?
The percentage of profitable transactions made by Julie Garlikov is ―.
    What is the average return per transaction made by Julie Garlikov?
    The average return per transaction made by Julie Garlikov is ―.
      What stocks does Julie Garlikov hold?
      Julie Garlikov holds: NBEVQ, NBY stocks.
        What was Julie Garlikov’s latest transaction?
        Julie Garlikov latest transaction was an Uninformative Buy of ―.
          What was Julie Garlikov's most profitable transaction?
          Julie Garlikov’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Julie Garlikov's role in NewAge?
            Julie Garlikov's role in NewAge is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.